Maccura Biotechnology Co.Ltd (SHE:300463)

SHE:300463 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	772.11	671.45	835.96	587.35	637.16	612.07
Trading Asset Securities	-	60.06	311.14	663.72	-	-
Cash & Short-Term Investments	772.11	731.52	1,147	1,251	637.16	612.07
Cash Growth	-19.55%	-36.23%	-8.31%	96.35%	4.10%	37.88%
Accounts Receivable	1,474	1,580	1,794	2,136	1,924	2,078
Other Receivables	24.74	32.41	67.74	19.41	21.61	24.17
Receivables	1,499	1,613	1,861	2,155	1,946	2,103
Inventory	973.22	901.58	907.49	1,039	1,076	1,075
Other Current Assets	439.61	393.84	306.33	251.87	195.77	235.76
Total Current Assets	3,684	3,640	4,222	4,698	3,855	4,025
Property, Plant & Equipment	3,494	3,407	2,929	2,513	2,015	1,742
Long-Term Investments	147.56	173.93	172.73	193.81	144.12	61.78
Goodwill	51.04	51.04	145.15	145.15	21.32	21.32
Other Intangible Assets	362.28	375.16	283.25	269.37	194.61	187.53
Long-Term Deferred Tax Assets	102.29	133.78	153.86	161.45	161.18	181.9
Long-Term Deferred Charges	143	119.6	142.4	113.42	95.51	64.23
Other Long-Term Assets	78.51	75.71	70.19	74.45	79.77	81.03
Total Assets	8,062	7,976	8,119	8,168	6,567	6,365
Accounts Payable	311.15	316.75	365.85	380.89	317.43	402.05
Accrued Expenses	56.55	136.39	136.86	152.61	131.59	149.29
Short-Term Debt	377.57	255.1	144.65	248.08	530.56	921.55
Current Portion of Long-Term Debt	224.4	202.42	330.56	139.1	130	70
Current Portion of Leases	-	8.86	14.48	13.2	13.64	-
Current Income Taxes Payable	37.68	5.69	19.31	39.84	23.6	63.48
Current Unearned Revenue	77.95	72.04	72.36	74.41	77	88.93
Other Current Liabilities	158.42	198.71	36.54	35.22	89.35	102.61
Total Current Liabilities	1,244	1,196	1,121	1,083	1,313	1,798
Long-Term Debt	244.1	184.12	162.5	285.8	424.1	329.7
Long-Term Leases	7.3	6.79	12.98	15.04	17.15	-
Long-Term Unearned Revenue	24.13	23.83	28.8	31.07	28.1	31.79
Long-Term Deferred Tax Liabilities	107.28	134	179.07	223.72	242.65	200.13
Other Long-Term Liabilities	7.74	7.94	3.83	-	-	-
Total Liabilities	1,634	1,553	1,508	1,639	2,025	2,360
Common Stock	612.47	612.47	612.47	612.47	556.47	557.11
Additional Paid-In Capital	1,784	1,783	1,781	1,781	279.51	369.15
Retained Earnings	4,202	4,179	4,147	4,047	3,624	2,906
Treasury Stock	-220.24	-220.24	-170.18	-170.18	-170.18	-48.44
Comprehensive Income & Other	1.22	14.18	14.89	23.29	8.34	12.62
Total Common Equity	6,379	6,369	6,385	6,293	4,299	3,797
Minority Interest	48.82	54.61	226.64	236.25	243.16	208.74
Shareholders' Equity	6,428	6,424	6,611	6,529	4,542	4,005
Total Liabilities & Equity	8,062	7,976	8,119	8,168	6,567	6,365
Total Debt	853.38	657.29	665.17	701.22	1,115	1,321
Net Cash (Debt)	-81.27	74.23	481.94	549.84	-478.29	-709.18
Net Cash Growth	-	-84.60%	-12.35%	-	-	-
Net Cash Per Share	-0.13	0.12	0.79	0.90	-0.86	-1.27
Filing Date Shares Outstanding	611.72	608.51	606.83	612.47	556.47	557.11
Total Common Shares Outstanding	611.72	608.51	606.83	612.47	556.47	557.11
Working Capital	2,440	2,444	3,102	3,614	2,542	2,227
Book Value Per Share	10.43	10.47	10.52	10.27	7.72	6.82
Tangible Book Value	5,966	5,943	5,956	5,879	4,083	3,588
Tangible Book Value Per Share	9.75	9.77	9.82	9.60	7.34	6.44
Buildings	-	783.53	783.35	739.86	732.5	733.07
Machinery	-	2,508	2,304	1,993	1,808	1,522
Construction In Progress	-	1,103	714.48	504.01	76.97	29.76

Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.